Research

Pages Tagged with "Research"

Best-selling author fights back against ovarian cancer
Deborah Harkness never stops teaching. A historian, the 58-year-old Harkness holds forth at the University of Southern California, captivating her students with insights on European history and the history of...
City of Hope appoints Marcel van den Brink, M.D., Ph.D., as president of City of Hope Los Angeles and National Medical Center, and chief physician executive
LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses...
Biomarkers may help detect prostate cancer risk in Black men
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments...
City of Hope receives $32M grant to advance novel therapies
Researchers at City of Hope have been awarded $32.3 million from the California Institute for Regenerative Medicine (CIRM) to support three novel Phase 1 clinical trials evaluating innovative cell and...
City of Hope researchers identify biomarkers that may detect risk of advance prostate cancer in Black men
The identification of a cell metabolism process found in Black men with diabetes and prostate cancer could one day lead to the development of a disease prediction tool for this...
CAR T cell therapy trial targets advanced ovarian cancer
Very few effective treatment options are available for patients with recurrent ovarian cancer and other solid tumors, but researchers are trying to change that.  Saul Priceman, Ph.D. Scientists at City of Hope recently...
City of Hope researchers develop a CAR T cell therapy for advanced ovarian cancer
LOS ANGELES — There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. ...
Targeted chemotherapy kills all tumor cells in preclinical research
Could a new molecule targeting a protein called PCNA help scientists develop a cancer-stopping pill? New preclinical research suggests it may be possible. Researchers aimed at a protein once thought to...
Young cancer survivor keeps it all in the City of Hope family
City of Hope has been a part of Natasha Shows’ life for almost as long as she can remember. Her mom, Bella Adeimy, spent nearly 36 years as a nurse...
City of Hope and Calidi Biotherapeutics announce first patient dosed in a Phase 1 clinical trial evaluating neural stem cells engineered to carry an oncolytic virus, CLD-101, in recurrent high-grade glioma patients
For Media:City of HopeLetisia Marquezlemarquez@coh.org(626) 476-7593Calidi BiotherapeuticsStephen ThesingSthesing@calidibio.com (858) 794-9600For Investors:Gilmartin GroupStephen Jasperstephen@gilmartinir.com LOS ANGELES and SAN DIEGO, Calif. ...